関連する実験動画
Updated: Aug 11, 2026

10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
まとめ
化学糖尿病 (軽度の糖尿病) の若い患者は,クロロプロパミド治療で長期的な寛解を達成することができます. このスルフォニル尿素療法は,ほとんどの参加者において持続的な正常な炭水化物耐性をもたらした.
科学分野:
- エンドクリノロジー エンドクリノロジー
- メタボリック障害 メタボリック障害
- 薬理学 薬理学とは
背景:
- 若年期発症糖尿病,特に化学糖尿病は,管理においてユニークな課題を提示しています.
- 若い糖尿病患者の長期的な寛解を達成するための口服低血糖剤の役割については,さらなる調査が必要です.
研究 の 目的:
- 青年発症化学糖尿病患者の寛解を達成するためのクロロプロパミドの長期的な有効性を評価する.
- 寛解の持続時間と,硫黄尿素治療後の持続的な通常の炭水化物耐性の可能性を評価する.
主な方法:
- 若年発症化学糖尿病の9人の患者を対象とした前向きな研究.
- 経口用クロロプロパミドによる治療は,治療中止後の炭水化物の耐性 (経口および静脈注射) の定期的な評価が続く.
- 炭水化物不耐症の変化を判断するための連続した静脈内投与試験の統計分析.
主要な成果:
- 9人の患者のうち6人は,炭水化物不耐性の統計的に有意な逆転を達成しました.
- これらの患者は平均して5.6年間 (範囲1~11年) 寛解状態に留まった.
- インスリン療法を必要とする2人の患者は,それぞれ3.5年と5年間寛解状態を維持しました.
結論:
- 化学糖尿病の若い患者のサブセットは,クロロプロパミド (sulphonylurea) で有意かつ持続的な寛解を達成することができます.
- これは,硫黄尿素治療が,特定の若年糖尿病集団における長期的な寛解を誘導するための有効な選択肢である可能性があることを示唆しています.
- この集団における寛解に成功するための予測要因を特定するために,さらなる研究が必要である.
関連する概念動画
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

